©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2013; 19(7): 1098-1103
Published online Feb 21, 2013. doi: 10.3748/wjg.v19.i7.1098
Published online Feb 21, 2013. doi: 10.3748/wjg.v19.i7.1098
Table 2 Comparison of adverse reactions between those receiving peginterferon-alfa 2a and those receiving peginterferon-alfa 2b
| Adverse reaction | Peginterferon-alfa 2a (n = 10) | Peginterferon-alfa 2b (n = 20) | Total |
| None | 0 | 5 | 5 |
| Flu-like symptoms | 4 | 5 | 9 |
| Weight loss | 1 | 3 | 4 |
| Hair loss | 1 | 3 | 4 |
| Headache | 2 | 2 | 4 |
| Aseptic meningitis | 1 | 0 | 1 |
| GI symptoms | 1 | 4 | 5 |
| Oral aphthae | 1 | 0 | 1 |
| Pruritus | 1 | 0 | 1 |
| Fat necrosis | 1 | 1 | 2 |
| Sleep disturbance | 2 | 0 | 2 |
| Lymphadenopathy | 1 | 0 | 1 |
| Absolute neutropenia | 0 | 2 | 2 |
| Anemia (HGB < 110 g/L) | 2 | 4 | 6 |
| Thrombocytopenia (platelets < 100 000 cells/μL) | 1 | 0 | 1 |
| Direct hyperbilirubinemia (mg/dL) | 1 | 0 | 1 |
| Indirect hyperbilirubinemia (mg/dL) | 0 | 1 | 1 |
- Citation: Rosen I, Kori M, Adiv OE, Yerushalmi B, Zion N, Shaoul R. Pegylated interferon alfa and ribavirin for children with chronic hepatitis C. World J Gastroenterol 2013; 19(7): 1098-1103
- URL: https://www.wjgnet.com/1007-9327/full/v19/i7/1098.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i7.1098